Last reviewed · How we verify

NCT02140775

Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS

Completed NA Results posted Last updated 16 March 2020
What this trial tests

NA trial testing Behavioral Activation Counseling in HIV Infection in 138 participants. Completed in 31 May 2019.

Timeline
1 April 2014
Primary endpoint
31 March 2019
31 May 2019

Quick facts

Lead sponsorNew York State Psychiatric Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment138
Start date1 April 2014
Primary completion31 March 2019
Estimated completion31 May 2019
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

New York State Psychiatric Institute

Who can join

Adults 18 to 70, any sex, with HIV Infection or Fatigue. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Goal Attainment Scale - Modified (GAS): Responder (Score of 3 - Goal Achieved) vs. Non-Responder (Score of 1 or 2 - Goal NOT Achieved) Primary · GAS Goal Responder vs. Goal Non-Responder will be assessed at Follow Up (3-6 months after the end of counseling)

Goal Attainment Scale - Prior to the beginning of counseling, the patient met with a member of the clinical team to develop an outcome GAS scale specific to their personal return to work goal. A goal was carefully established to be obtainable within the framework of 3-6 months, and to have observable anchors that could be scored on 3 outcome levels. A score of 3 indicates that they achieved their predetermined work goal and they were considered a "Responder" to the counseling. A score 2 indicates that some of the specific steps were taken towards the goal, but that it was not fully achieved. A

GroupValue95% CI
Behavioral Activation Counseling29
Supportive Counseling9
Environmental Reward Observation Scale (EROS) Secondary · EROS will be measured at Follow-up (3-6 months after the end of counseling)

This 10-item scale developed to assess changes in activity level and is based on the premise of response-contingent reinforcement. Score Range = 10 - 40 Higher scores suggest higher environmental reward.

GroupValue95% CI
Behavioral Activation Counseling27± 7
Supportive Counseling31± 8
Behavioral Activation for Depression Scale (BADS) Secondary · BADS will be measured Follow-up (3-6 months after the end of counseling)

This 25 item scale total score is used to monitor change in Behavioral Activation (BA) protocols. Score Range = 0 - 150 Higher scores suggest greater activation and less avoidance, as well as less social and work impairment.

GroupValue95% CI
Behavioral Activation (BA) Counseling99± 28
Supportive Counseling (SC)102± 27

Sponsor's own description

The current study is a randomized clinical trial comparing Behavioral Activation counseling with supportive counseling for HIV+ participants presenting with clinically significant fatigue whose energy has improved with armodafinil, who have the goal of returning to work or vocational training but have not done so on their own. A second cohort of HIV+ participants without significant fatigue at baseline, but who also have the goal of returning to work, will also be randomized to either Behavioral Activation counseling or supportive counseling. In both cohorts, the primary outcome is level of success regarding an employment related goal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for HIV Infection

Currently open trials in the same condition.

Other New York State Psychiatric Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02140775.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing